IRALINE is a Medical Device based on intra-articular injections of linear Hyaluronic Acid (HA) for the restoral of the correct joint physiology through temporary viscosupplementation of the synovial fluid in patients affected by osteoarthritis.
Thanks to its viscoelastic proprieties, Hyaluronic Acid plays a primary role in the development of cartilage and the maintenance of the synovial fluidsurrounding the joints, acting both as a lubricant and as a shock absorber.
IRALINE, by increasing the viscosity of the synovial fluid and promoting lubrication, is indicated in case of pain and reduced mobility caused by degenerative or traumatic disorders of the synovial joints, providing better cushioning support for joints to move freely without pain.
The dosage consists in a 2 ml syringe containing linear Hyaluronic Acid at a 2% concentration. Injections may be repeated over time, depending on the patient’s symptoms.
Thanks to the sophisticated quality standards, LKC Pharma takes intra-articular injections to a completely new level: the high degree of purity, the low concentration of nucleic acids and proteins, in addition to an extremely low endotoxin level (below the limits imposed by the European Pharmacopoeia) make IRALINE an extremely safe product for both patients and doctors.